Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-04-30

FDA Approved: RISPERIDONE — Original Application (Par Health USA, LLC)

View source ↗

Summary

FDA approves Par Health USA, LLC's original application for a generic risperidone product, expanding access to the standard indications for risperidone. Indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

ORIG AP for RISPERIDONE (RISPERIDONE)